Related Experiment Video
Updated: Sep 11, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Telehealth to Promote Adoption of Automated Insulin Delivery Systems in Youth With Risk Factors for Adverse Diabetes
Lisa Rasbach1, Ginna Purrington1, Deanna Adkins1
1Division of Pediatric Endocrinology and Diabetes, Duke University Medical Center, Durham, North Carolina.
Abstract:
PurposeThe purpose of this study is to assess the effects of an intensive telehealth intervention on technology adoption and glycemic control in historically marginalized youth with diabetes mellitus on Medicaid.MethodsThis quality improvement project included youth (ages 12-18) with diabetes utilizing insulin therapy. Eligible participants were diagnosed at least 12 months prior to enrollment and had an A1C ≥9%, Medicaid insurance, and willingness to use a continuous glucose monitor (CGM) and an insulin pump. Participants received scheduled weekly contact (phone/video) with a certified diabetes care and education specialist and monthly video visits with a nurse practitioner.ResultsYouth (N = 18, 61% female, 78% non-White, diabetes duration 4.6±3 years) had baseline mean A1C of 11.4% ± 2.0%; 22% were on pump therapy. There was a sustained improvement between baseline A1C (mean 11.4% ± 2.0%) and 3 months (mean 10.5% ± 2.7%; P = .01) and 6 months (mean 9.8% ± 2.4%, 83.6 mmol/mol; P = .003). Significantly more participants used pump therapy by the end (n = 16) compared to baseline (n = 4; P < .0001). Participants wore CGMs more at 3 (P = .04) and 6 months (P = .0004) during the intervention compared to 3 and 6 months prior.ConclusionsThis telehealth intervention provided interim improvement in A1C and increased adoption of diabetes technology in a low socioeconomic status cohort from a historically marginalized population. Ongoing monitoring is needed to evaluate the durability of this intervention.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

